Skip to main content
. 2023 Oct 26;65:102268. doi: 10.1016/j.eclinm.2023.102268

Table 2.

Response and relapse rates, stratified by CAR indication.

Refractory (N = 30) 1st Relapse (N = 66) ≥2nd Relapse (N = 87) p-value
Complete response rate
 Morphology 28 (93%) 56 (85%) 71 (82%) 0.3061
 MRD
 Flow cytometry 28 (93%) 52 (79%) 67 (77%) 0.1324
Relapse rate∗
 Overall 7 (25%) 17 (30%) 28 (39%) 0.3490
CD19 status at relapse
 CD19+ 6 (86%) 10 (59%) 14 (50%)
 CD19− 1 (14%) 7 (41%) 14 (50%) 0.2897

Relapse rate∗ amongst morphologic CR responders.